ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1371

Complement-Mediated Neutrophil Lysis-a Mechanism Promoting Hypercitrullination in Rheumatoid Arthritis?  

Tal Gazitt1, Christian Lood2, Jeffrey Ledbetter3 and Keith B. Elkon3, 1Rheumatology, University of Washington, Seattle, WA, 2University of Washington, Lund, Sweden, 3Division of Rheumatology, University of Washington, Seattle, WA

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: citrullination, complement and neutrophils

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 9, 2015

Title: Innate Immunity and Rheumatic Disease Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose:

Protein citrullination, the post-translational conversion of arginine to citrulline, mediated by peptidylarginine deiminase (PAD) enzymes, is considered a likely mechanism for the stimulation of anti-citrullinated protein antibodies (ACPA) in patients with rheumatoid arthritis (RA).  Hypercitrullination, the citrullination of multiple intracellular proteins, was recently demonstrated in synovial fluid cells from RA patients but was not found in other physiologic processes involving citrullination, such as NETosis (Romero et al., Sci Transl Med, 2013). This unique form of citrullination is proposed to occur via immune-mediated, pore-forming membranolytic pathways causing neutrophil cell death; one mediated by cytotoxic cells through the perforin-granzyme pathway, and the other mediated by complement activation and formation of the membrane attack complex (MAC). Since the evidence to support this hypothesis was derived from simulated in vitro systems, we explored the naturally occurring humoral mechanisms required for induction of complement-mediated neutrophil lysis.  

Methods:

Neutrophils (PMNs) isolated from synovial fluid (SF) or peripheral blood (PB) of RA patients as well as in healthy controls (HC) were exposed to the inflammatory milieu found in RA joints. PMNs isolated from SF (n=3) and PB (n=25)  of ACPA-positive RA patients as well as PB of HC (n=10) were screened for anti-neutrophil binding IgG, C3bi and C5b-9 complement component deposition, as well as PMN viability using annexin V and propidium iodide staining by flow cytometry analysis.  In addition, PMNs isolated from HC were incubated with serum or SF from RA patients or normal human serum from the same healthy controls. 

Results:

In the periphery, in the majority of patient samples, RA PMNs had highly increased mean fluorescence intensity (MFI) ratio for C3bi cell-surface deposition as compared to healthy controls (p<0.05), but no differences were seen in MFI of C5b-9 deposition. However, in SF samples, PMNs had elevated MFI ratio of C5b-9 as compared to PB PMNs from HC (p<0.05) and paired RA patients (P< 0.0001). Complement deposition on SF PMNs was also associated with decreased cell surface expression of the complement regulatory molecule CD46, as well as increased cell death, with more than 50% of the SF PMNs undergoing secondary necrosis, consistent with the notion of complement-mediated killing of SF PMNs.  Moreover, incubation of HC PMNs with 15% RA SF, but not 15% serum from paired RA patients or HC induced C3bi and C5b-9 deposition, reduction in CD46 expression, and PMN lysis via secondary necrosis.

Conclusion:

RA PMNs, in particular SF PMNs, demonstrate increased complement deposition associated with PMN cell death both in vivo and in vitro. Elucidating the cause of complement deposition and the role of complement regulatory proteins in promoting PMN lysis may help to uncover a mechanism for hypercitrullination, ACPA formation and RA disease propagation.


Disclosure: T. Gazitt, None; C. Lood, None; J. Ledbetter, None; K. B. Elkon, None.

To cite this abstract in AMA style:

Gazitt T, Lood C, Ledbetter J, Elkon KB. Complement-Mediated Neutrophil Lysis-a Mechanism Promoting Hypercitrullination in Rheumatoid Arthritis?   [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/complement-mediated-neutrophil-lysis-a-mechanism-promoting-hypercitrullination-in-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/complement-mediated-neutrophil-lysis-a-mechanism-promoting-hypercitrullination-in-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology